ProMECE-CytaBOM vs MACOP-B in Advanced Aggressive Non-Hodgkin's Lymphoma: Long Term Results of a Multicenter Study of the Italian Lymphoma Study Group (GISL)Vittorio Silingardi, Caterina Mauri, Paolo G. Gobbi et al.|Leukemia & lymphoma/Leukemia and lymphoma|1995Cited by 22
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL).Giuseppe Longo, Vittorio Silingardi, Claudia Fiorani et al.|PubMed|1999Cited by 11